These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4982303)

  • 21. Letter: Oral administration of aspirin.
    Blake MI
    Am J Hosp Pharm; 1975 Sep; 32(9):879-80. PubMed ID: 1190241
    [No Abstract]   [Full Text] [Related]  

  • 22. [In vivo drug release from microencapsulated acetylsalicylic acid with simultaneous alcohol uptake].
    Frömming KH; Schwabe L
    Arzneimittelforschung; 1980; 30(5):836-9. PubMed ID: 7190431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of propoxyphene and salicylate concentrations in human plasma following the administration of propoxyphene napsylate and aspirin.
    Nash JF; Scholz NE; Maxwell SB
    Toxicol Appl Pharmacol; 1971 Jul; 19(3):537-45. PubMed ID: 5571353
    [No Abstract]   [Full Text] [Related]  

  • 24. Salicylate therapy and drug interaction in rheumatoid arthritis.
    Barraclough DR; Muirden KD; Laby B
    Aust N Z J Med; 1975 Dec; 5(6):518-23. PubMed ID: 1065285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absorption of theophylline from conventional and sustained-release tablets.
    Mellstrand T; Svedmyr N; Fagerström PO
    Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of steady state plasma theophylline concentrations with conventional and sustained release formulations.
    Mellstrand T; Svedmyr K; Svedmyr N
    Eur J Respir Dis; 1982 Jan; 63(1):31-4. PubMed ID: 7040098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin dosages for the dog.
    Yeary RA; Brant RJ
    J Am Vet Med Assoc; 1975 Jul; 167(1):63-4. PubMed ID: 1150495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma salicylate concentrations in immature dogs following aspirin administration: comparison with adult dogs.
    Waters DJ; Bowers LD; Cipolle RJ; Caywood DD; Bill RL
    J Vet Pharmacol Ther; 1993 Sep; 16(3):275-82. PubMed ID: 8230398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absorption of theophylline from conventional and sustained-release tablets.
    Fagerström PO; Mellstrand T; Svedmyr N
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained-release aspirin in children.
    Gotoff SP; McCue SA; Wendell PW
    J Pediatr; 1968 Jul; 73(1):127-31. PubMed ID: 5658621
    [No Abstract]   [Full Text] [Related]  

  • 32. Determination of plasma aspirin and salicylic acid concentrations after low aspirin doses by high-performance liquid chromatography with post-column hydrolysis and fluorescence detection.
    Siebert DM; Bochner F
    J Chromatogr; 1987 Sep; 420(2):425-31. PubMed ID: 3693513
    [No Abstract]   [Full Text] [Related]  

  • 33. Is all aspirin alike?
    Med Lett Drugs Ther; 1974 Jul; 16(14):57-9. PubMed ID: 4427568
    [No Abstract]   [Full Text] [Related]  

  • 34. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
    Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
    Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Steady-state bioavailability of two sustained-release quinidine preparations: quinidine gluconate versus quinidine sulfate.
    Taggart WV; Holyoak W
    Clin Ther; 1983; 5(4):357-64. PubMed ID: 6871920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tablets. XVII. Effect of pressure on the liberation in vitro of sodium salicylate from prolonged-action tablets].
    Terrier JL; Cruaud-Mangenot O; Duchène D; Puisieux F
    Pharm Acta Helv; 1976; 51(5):144-52. PubMed ID: 967910
    [No Abstract]   [Full Text] [Related]  

  • 37. STUDIES OF DELAYED-ACTION MEDICATION. IV. SALICYLATES.
    HOLLISTER LE; KANTER SL
    Clin Pharmacol Ther; 1965; 6():5-11. PubMed ID: 14253285
    [No Abstract]   [Full Text] [Related]  

  • 38. Controlled trial of clinical utility of serum salicylate monitoring in rheumatoid arthritis.
    Tugwell P; Hart L; Kraag G; Park A; Dok C; Bianchi F; Goldsmith C; Buchanan WW
    J Rheumatol; 1984 Aug; 11(4):457-61. PubMed ID: 6481719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Slow release aspirin in the elderly.
    Aihie AP; Halpern SM; Streete PJ; Crome P
    J R Soc Med; 1994 Mar; 87(3):183. PubMed ID: 8192781
    [No Abstract]   [Full Text] [Related]  

  • 40. SUSTAINED-RELEASE ASPIRIN TABLET USING AN INSOLUBLE MATRIX.
    VORA MS; ZIMMER AJ; MANEY PV
    J Pharm Sci; 1964 May; 53():487-92. PubMed ID: 14193877
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.